american diabetes association 'history of pancreatitis' glp-1 receptor agonist The Emerging Role Glucagon-Like Peptide-1 Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis Association of glucagon-like peptide-1 receptor

The key findings include: 9 total patients (mean age 57.4 years, range 37-77 years) developed significant vision complications

Eduard Vieta has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbott, AbbVie, Adamed, Alcediag, Angelini, Biogen, Beckley-Psytech, Biohaven, Boehringer-Ingelheim, Casen-Recordati, Celon Pharma, Clariane, Compass, Dainippon Sumitomo Pharma, Esteve, Ethypharm, Ferrer, Gedeon Richter, GH Research, Glaxo-Smith Kline, HMNC, Intra-Cellular therapies, Idorsia, Johnson & Johnson, Lundbeck, Luye Pharma, Medincell, Merck, Mitsubishi Tanabe Pharma, Newraxpharm, Newron, Novartis, Organon, Orion Corporation, Otsuka, Roche, Rovi, Sage, Sanofi-Aventis, Sunovion, Takeda, Teva, and Viatris, outside the submitted work

S.PedersenB

Healthy Fats: Avocados, olive oil, nuts, and fatty fish are all examples of healthy fats, and they trigger the release of GLP-1

[Preprint] (2025)

Beyond glycaemic control, a key advantage of this combination lies in its multifaceted metabolic benefits